Regulus Therapeutics Inc. (Nasdaq: RGLS) announced that it has expanded its clinical trial collaboration agreement with GSK (NYSE: GSK) for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE